Don't miss our holiday offer - up to 50% OFF!
ARA290 (Cibinetide) – 16mg (10 vials)
ARA-290 (Cibinetide) – 16mg – 10 Vials
ARA-290, also known as cibinetide, is a synthetic peptide derived from a region of erythropoietin (EPO). It has been investigated in scientific research involving tissue-protective signaling and inflammatory pathways. This listing describes a 16mg, 10-vial presentation. Confirm whether 16mg refers to each vial or the complete package, along with the exact formulation and supplier specifications.
ARA-290 (Cibinetide) – 16mg – 10 Vials
Product Overview
ARA-290, also known as cibinetide, is a synthetic peptide based on a specific region of erythropoietin (EPO). Unlike full-length EPO, it was developed to investigate tissue-protective signaling without relying on the same red-blood-cell production activity associated with EPO.
It has attracted scientific interest for its potential interactions with tissue-protective and inflammatory signaling pathways. However, research findings should not be interpreted as proof of established therapeutic benefits for this particular product presentation.
Product Details
- Product Name: ARA-290
- Alternative Name: Cibinetide
- Listed Strength: 16mg
- Package Quantity: 10 vials
- Product Category: Synthetic Peptide
- Research Area: Tissue-protective signaling and inflammatory pathways
- Peptide Sequence: Confirm with supplier
- Manufacturer: Confirm with supplier
- Formulation: Confirm with supplier
- Storage Requirements: Follow verified manufacturer documentation
Scientific Background
Cibinetide has been investigated for its interaction with tissue-protective signaling mechanisms associated with the innate repair receptor pathway. Scientific studies have explored its relationship with inflammatory responses and cellular protection.
Although research has examined potential therapeutic applications, the findings do not establish that every commercial ARA-290 product is safe or effective for human use.
Product Verification
Before publishing or distributing this product, confirm:
- Whether 16mg refers to each vial or the entire package
- Exact peptide sequence and chemical identity
- Manufacturer identity and product labeling
- Batch identification and available quality documentation
- Formulation and storage requirements
- Applicable regulatory status and distribution requirements
Important Safety and Regulatory Information
ARA-290 (cibinetide) is an investigational peptide. Its research history does not establish that this specific vial product is an approved medicine or that it is suitable for human administration.
This description is for product identification and general research information only. It is not medical advice, a dosing guide, or a recommendation for human administration. Avoid unsupported claims about treating inflammation, nerve damage, pain, or other medical conditions. Verify the product’s identity and regulatory status before publication.






Reviews
There are no reviews yet.